Elevation Oncology Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2021	FY 2020
Period Ending	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	284.68	-1,541
Depreciation & Amortization	140.1	154.96
Asset Writedown & Restructuring Costs	-	70
Loss (Gain) From Sale of Investments	-44.2	11.18
Stock-Based Compensation	18.54	-
Provision & Write-off of Bad Debts	244.27	57.61
Other Operating Activities	-985.76	1,156
Change in Accounts Receivable	-1,847	-639.76
Change in Inventory	11	-34.36
Change in Accounts Payable	1,065	57.95
Change in Other Net Operating Assets	-427.11	-149.57
Operating Cash Flow	-1,540	-857.55
Capital Expenditures	-53.86	-7.8
Sale (Purchase) of Intangibles	-17.06	-
Investment in Securities	1,021	1,054
Other Investing Activities	-0	-
Investing Cash Flow	950.28	1,047
Short-Term Debt Issued	1,562	340.74
Total Debt Issued	1,562	340.74
Short-Term Debt Repaid	-811.78	-277.16
Long-Term Debt Repaid	-243.53	-85.38
Total Debt Repaid	-1,055	-362.54
Net Debt Issued (Repaid)	506.93	-21.8
Other Financing Activities	-0	-0
Financing Cash Flow	3,507	-21.8
Net Cash Flow	2,917	167.18
Free Cash Flow	-1,594	-865.35
Free Cash Flow Margin	-20.06%	-12.18%
Free Cash Flow Per Share	-3987.52	-2163.13
Cash Interest Paid	67.96	62.74
Cash Income Tax Paid	-8.03	5.84
Levered Free Cash Flow	-1,678	-
Unlevered Free Cash Flow	-1,444	-
Change in Net Working Capital	1,084	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.